Top Analyst Upgrades and Downgrades: AIG, Freeport-McMoRan, Frontier Communications, Noble Energy, Occidental, Spark Therapeutics, Target and More

Print Email

Northern Trust Corp. (NASDAQ: NTRS) was raised to Outperform from Market Perform with a $126 target price (versus a $95.81 close) at Wells Fargo. Northern Trust has a $114.25 consensus analyst target, and its 52-week trading range is $87.98 to $115.61.

Oasis Petroleum Corp. (NYSE: OAS) was raised to Hold from Sell with an $11 price target (versus a $9.89 close) at SunTrust Robinson Humphrey. The 52-week range is $7.31 to $14.57 and the consensus target price is $16.53.

Occidental Petroleum Corp. (NYSE: OXY) was raised to Outperform from In-Line with an $88 price target (versus a $73.34 close, after a 4.8% gain) at Evercore ISI.

Progressive Corp. (NYSE: PGR) was raised to Overweight from Equal Weight with an $84 price target (versus a $69.78 close) at Morgan Stanley. The 52-week range is $50.14 to $72.72 and the consensus target price is $73.00.

RenaissanceRe Holdings Ltd. (NYSE: RNR) was raised to Buy from Hold with a $150 price target (versus a $126.55 close) at Deutsche Bank. The consensus target price is $139.90.

Spark Therapeutics Inc. (NASDAQ: ONCE) was last seen up 6% at $44.30 after reporting a narrower loss. Wedbush raised it to Neutral from Underperform with a $40 price target, noting that there are challenges ahead but also that Spark’s risk/reward scenario has improved. Raymond James raised Spark Therapeutics to Strong Buy from Outperform, and B. Riley raised it was to Buy from Neutral.

Target Corp. (NYSE: TGT) was raised to Outperform from Market Perform with a $100 target price (versus an $86.67 close) at Cowen. Target has a consensus target price of $89.51.

United Microelectronics Corp. (NYSE: UMC) was downgraded to Neutral from Buy at UBS, a day after its shares rose 4% to $1.78. Its 52-week range is $1.69 to $3.14.

USA Compression Partners L.P. (NYSE: USAC) was raised to Outperform from Sector Perform with a $21 price target (versus a $14.19 close) at RBC Capital Markets. The 52-week range is $14.01 to $19.33 and the consensus target price is $20.14.

Western Gas Partners L.P. (NYSE: WES) was raised to Buy from Neutral with a $51 price objective (versus a $41.07 close) at Merrill Lynch. The 52-week range is $38.35 to $54.40. The consensus target price is $54.82.

Zions Bancorp (NASDAQ: ZION) was raised to Overweight from Neutral and the price target was lifted up to $57 from $54 (versus a $49.19 close) at Piper Jaffray. The consensus target price is $57.08.

Tuesday’s top analyst upgrades and downgrades were in shares of AbbVie, AMAG Pharmaceutical, Crocs, HCA, Kellogg, Kosmos Energy, Mylan, Pandora Media, Square and many more.

I'm interested in the Newsletter